Dr. Oh gives overview of oligometastatic prostate cancer and emergent therapies

“We have new therapies, both AR-targeted therapies, as well as the use of SBRT, or targeted radiotherapy, that have changed the landscape,” says William K. Oh, MD.

In this video, William K. Oh, MD, discusses why oligometastatic prostate cancer is a “hot topic” in urology right now, and what therapies are expected to emerge in the near future to help manage this complex disease state. These concepts stem from Oh’s presentation, which was given at the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies. Oh is a clinical professor of medicine at the Icahn School of Medicine, Mount Sinai in New York, New York.